RASGRP4 and Arthritis: In terms of the relevance of our new data to inflammatory diseases, it is now possible that the findings that RasGRP4 participates in experimental arthritis and colitis [9] could be a consequence of dysregulation of DCs rather than MCs or synovial fibroblasts.